ArticleJournal of molecular histology2026
Green fabrication of silver nanoparticles using Corallocarpus epigaeus (Hook.f.) Cogn. rhizome extract: phytochemical characterization and evaluation of antioxidant, antimicrobial, and anticancer activity against HT-29 cells.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Corallocarpus epigaeus is an ethnomedical plant with numerous bioactive phytochemicals but the potential of the plant in green nanotechnology and anticancer studies is underexplored. Phytochemical screening was conducted and AgNPs biosynthesis was done using rhizome extract as a reducing and capping agent. The nanoparticles were characterized using UV-Vis spectroscopy, GC-MS, FTIR, Raman spectroscopy, AFM, and SEM, DLS and Zeta potential analyser. Antioxidant activity was measured using Phosphomolybdenum assay, antibacterial using agar well diffusion with Escherichia coli (MTCC 40), (MTCC 121) and cytotoxicity of HT-29 colon cancer cells using MTT assay. Alkaloids were in large quantity, flavonoids, phenolics, saponins and phytosteroids were in moderate amounts and trace amounts of tannins and quinones. UV-Visible spectroscopy confirmed nanoparticle formation with a stable surface plasmon resonance peak at 430 nm. XRD analysis revealed a highly crystalline nanostructure with well-defined diffraction peaks, confirming the formation of nanocrystalline silver. DLS analysis indicated a predominant nanoscale population with an average hydrodynamic size of 55-86 nm, although some aggregation was observed. Zeta potential measurement (- 21.0 mV) suggested moderate colloidal stability due to phytochemical capping. SEM and AFM analyses confirmed predominantly spherical, moderately dispersed nanoparticles with nanoscale morphology with a 55 nm diameter. The AgNPs had a higher antioxidant capacity (0.0251 absorbance units) compared to crude extract (0.0078). It showed a strong antibacterial activity with the inhibition zones of 25 mm (B. subtilis) and 24 mm (E. coli) achievable at 150 µL. The AgNPs demonstrated a high level of cytotoxicity towards HT-29 cells with an IC50 of 31.2 ug/ml and-apoptotic morphology. AgNPs (55 nm) mediated by C. epigaeus rhizome exhibits good antioxidant, antibacterial and anticancer effects that can be used to justify the possibility of using C. epigaeus rhizome as plant-based nanotherapeutics. Moreover, the eco-friendly approach contributes to the global objectives of United Nations Sustainable Development Goal 3: Good Health and Well-Being, United Nations Sustainable Development Goal 9: Industry, Innovation and Infrastructure, and United Nations Sustainable Development Goal 12: Responsible Consumption and Production, by promoting sustainable nanotechnology, innovative biomedical research, and environmentally responsible production methods.
Indexed as
Identifiers
42350836What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.